Use Akorn to protect against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Akorn will likely underperform.
The median price of Akorn for the period between Sat, Apr 20, 2013 and Mon, May 20, 2013 is 14.69 with a coefficient of variation of 2.71. The daily time series for the period is distributed with a sample standard deviation of 0.4, arithmetic mean of 14.65, and mean deviation of 0.33. The Stock received some media coverage during the period.
Akorn Inc [AKRX] is traded on NASDAQ in USA. It is located in Akorn, Inc.Lake Forest, IL and employs 759 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 1.41 B. Akorn Inc conducts business under Healthcare sector and is part of Drugs - Generic industry. This company has 95.92 M outstanding shares of which 12.38 M shares are presently shorted by private and institutional investors with about 19.3 trading days to cover.
Akorn, Inc. engages in the manufacture and marketing of diagnostic and therapeutic ophthalmic pharmaceuticals products, hospital drugs, and injectable pharmaceuticals in the United States and internationally. more
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory